TriSalus Life Sciences, Inc. · CIK 1826667
TriSalus Life Sciences, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
May 8, 2025
through May 8, 2025
through May 8, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $22,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $22,000,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (1)
-
0001231919-25-000045D · May 8, 2025 · BiotechnologyOffering: $22,000,000Sold: $22,000,000